Caren Grossbard Solomon, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Climate Change | 6 | 2024 | 493 | 2.070 |
Why?
|
| Fossil Fuels | 2 | 2024 | 49 | 1.720 |
Why?
|
| Climate | 2 | 2022 | 146 | 1.410 |
Why?
|
| Pre-Eclampsia | 11 | 2017 | 1229 | 1.020 |
Why?
|
| Pregnancy Complications, Cardiovascular | 7 | 2011 | 515 | 0.990 |
Why?
|
| Environmental Pollution | 2 | 2022 | 123 | 0.950 |
Why?
|
| Diabetes, Gestational | 16 | 2015 | 1248 | 0.810 |
Why?
|
| Air Pollution | 4 | 2022 | 2342 | 0.690 |
Why?
|
| Pregnancy Proteins | 2 | 2016 | 222 | 0.690 |
Why?
|
| Global Warming | 1 | 2020 | 77 | 0.670 |
Why?
|
| Hypertension, Pregnancy-Induced | 6 | 2016 | 517 | 0.650 |
Why?
|
| Glucose Intolerance | 7 | 2014 | 575 | 0.640 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 2 | 2016 | 557 | 0.580 |
Why?
|
| Health | 1 | 2019 | 398 | 0.530 |
Why?
|
| Estrogen Replacement Therapy | 3 | 2016 | 1208 | 0.470 |
Why?
|
| Disease | 1 | 2019 | 672 | 0.450 |
Why?
|
| Hypertension | 11 | 2022 | 8527 | 0.440 |
Why?
|
| Air Pollutants | 3 | 2022 | 2870 | 0.430 |
Why?
|
| Pregnancy Outcome | 5 | 2015 | 2916 | 0.410 |
Why?
|
| Physician's Role | 1 | 2019 | 916 | 0.390 |
Why?
|
| Pregnancy Complications | 7 | 2015 | 2946 | 0.390 |
Why?
|
| Antihypertensive Agents | 6 | 2015 | 2018 | 0.360 |
Why?
|
| Pregnancy | 36 | 2017 | 29831 | 0.360 |
Why?
|
| Osteoporosis, Postmenopausal | 3 | 2003 | 396 | 0.340 |
Why?
|
| Cardiovascular Diseases | 10 | 2024 | 15476 | 0.330 |
Why?
|
| Estradiol | 1 | 2016 | 1935 | 0.320 |
Why?
|
| Postmenopause | 1 | 2016 | 2513 | 0.280 |
Why?
|
| Ramipril | 1 | 2006 | 102 | 0.260 |
Why?
|
| Aspirin | 1 | 2017 | 3134 | 0.250 |
Why?
|
| Public Health | 1 | 2019 | 2665 | 0.250 |
Why?
|
| Weight Gain | 8 | 2016 | 2346 | 0.250 |
Why?
|
| Diabetes Mellitus, Type 2 | 14 | 2022 | 12127 | 0.240 |
Why?
|
| Menstrual Cycle | 3 | 2022 | 539 | 0.230 |
Why?
|
| Prenatal Care | 5 | 2015 | 1134 | 0.220 |
Why?
|
| Obesity | 11 | 2016 | 12918 | 0.220 |
Why?
|
| Heat Stress Disorders | 1 | 2024 | 79 | 0.220 |
Why?
|
| Authorship | 1 | 2006 | 283 | 0.210 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 3 | 2007 | 1517 | 0.210 |
Why?
|
| Risk Factors | 40 | 2024 | 74055 | 0.210 |
Why?
|
| Gastroplasty | 1 | 2004 | 157 | 0.210 |
Why?
|
| Exercise | 11 | 2015 | 5874 | 0.210 |
Why?
|
| Bibliometrics | 1 | 2006 | 350 | 0.210 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3080 | 0.210 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3200 | 0.200 |
Why?
|
| Blood Glucose | 7 | 2014 | 6380 | 0.200 |
Why?
|
| Postnatal Care | 2 | 2015 | 262 | 0.200 |
Why?
|
| Oligomenorrhea | 1 | 2001 | 42 | 0.200 |
Why?
|
| Delivery of Health Care | 1 | 2019 | 5332 | 0.190 |
Why?
|
| Oxygen Inhalation Therapy | 2 | 2015 | 410 | 0.180 |
Why?
|
| Periodicity | 1 | 2002 | 347 | 0.180 |
Why?
|
| Humans | 83 | 2024 | 760437 | 0.180 |
Why?
|
| Motor Activity | 4 | 2013 | 2710 | 0.180 |
Why?
|
| Body Mass Index | 15 | 2016 | 12932 | 0.180 |
Why?
|
| Physicians, Women | 1 | 2006 | 507 | 0.170 |
Why?
|
| Fetal Macrosomia | 2 | 2015 | 140 | 0.170 |
Why?
|
| Atherosclerosis | 1 | 2016 | 3407 | 0.170 |
Why?
|
| Health Behavior | 5 | 2019 | 2637 | 0.170 |
Why?
|
| Coronary Disease | 7 | 2007 | 5919 | 0.170 |
Why?
|
| Diphosphonates | 2 | 2002 | 636 | 0.160 |
Why?
|
| Hypercholesterolemia | 3 | 2022 | 1142 | 0.160 |
Why?
|
| Diabetic Angiopathies | 2 | 2002 | 804 | 0.160 |
Why?
|
| Female | 63 | 2022 | 391875 | 0.150 |
Why?
|
| Faculty, Medical | 1 | 2006 | 1202 | 0.150 |
Why?
|
| Health Maintenance Organizations | 1 | 2000 | 660 | 0.150 |
Why?
|
| Informed Consent | 2 | 2015 | 1006 | 0.150 |
Why?
|
| Insulin Resistance | 3 | 2014 | 3956 | 0.140 |
Why?
|
| Cities | 1 | 2019 | 543 | 0.140 |
Why?
|
| Coronary Artery Disease | 1 | 2016 | 6388 | 0.130 |
Why?
|
| Gastric Bypass | 1 | 2004 | 817 | 0.130 |
Why?
|
| Kidney Failure, Chronic | 1 | 2008 | 2462 | 0.130 |
Why?
|
| Imidazoles | 1 | 2002 | 1179 | 0.130 |
Why?
|
| Adrenergic Agonists | 1 | 1995 | 58 | 0.130 |
Why?
|
| Insulin | 6 | 2005 | 6591 | 0.130 |
Why?
|
| Periodicals as Topic | 1 | 2006 | 1463 | 0.120 |
Why?
|
| Taxes | 1 | 2017 | 221 | 0.120 |
Why?
|
| Public Opinion | 1 | 2019 | 484 | 0.120 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 1999 | 376 | 0.120 |
Why?
|
| Vulnerable Populations | 1 | 2020 | 700 | 0.120 |
Why?
|
| Puerto Rico | 5 | 2016 | 375 | 0.120 |
Why?
|
| Absorptiometry, Photon | 1 | 2000 | 1736 | 0.120 |
Why?
|
| Paraneoplastic Endocrine Syndromes | 1 | 1994 | 29 | 0.120 |
Why?
|
| Bicycling | 1 | 1995 | 177 | 0.120 |
Why?
|
| Disasters | 1 | 2020 | 518 | 0.120 |
Why?
|
| Propranolol | 1 | 1995 | 489 | 0.110 |
Why?
|
| Osteomalacia | 1 | 1994 | 60 | 0.110 |
Why?
|
| Norepinephrine | 2 | 1995 | 897 | 0.110 |
Why?
|
| Adrenal Glands | 1 | 1996 | 551 | 0.110 |
Why?
|
| Retinopathy of Prematurity | 2 | 2015 | 439 | 0.110 |
Why?
|
| Nurses | 5 | 2003 | 2471 | 0.110 |
Why?
|
| Prospective Studies | 25 | 2022 | 54339 | 0.110 |
Why?
|
| Epinephrine | 2 | 1995 | 792 | 0.110 |
Why?
|
| Hyperaldosteronism | 1 | 1996 | 244 | 0.100 |
Why?
|
| Postpartum Period | 2 | 2014 | 1172 | 0.100 |
Why?
|
| Oxygen | 2 | 2015 | 4222 | 0.100 |
Why?
|
| Human Experimentation | 1 | 2013 | 123 | 0.100 |
Why?
|
| Glucose Tolerance Test | 4 | 2013 | 1178 | 0.100 |
Why?
|
| Feeding Behavior | 2 | 2015 | 3188 | 0.100 |
Why?
|
| Cushing Syndrome | 1 | 1994 | 241 | 0.100 |
Why?
|
| United States Food and Drug Administration | 1 | 2020 | 1663 | 0.100 |
Why?
|
| United States | 15 | 2020 | 72202 | 0.100 |
Why?
|
| Adult | 44 | 2022 | 220781 | 0.090 |
Why?
|
| Parity | 3 | 2009 | 927 | 0.090 |
Why?
|
| Bone Density | 2 | 2002 | 3549 | 0.090 |
Why?
|
| Hypercalcemia | 1 | 1994 | 423 | 0.090 |
Why?
|
| Acromegaly | 1 | 1994 | 310 | 0.090 |
Why?
|
| Risk Reduction Behavior | 2 | 2015 | 1112 | 0.090 |
Why?
|
| Politics | 1 | 2017 | 814 | 0.090 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 1995 | 1240 | 0.090 |
Why?
|
| Cholesterol | 1 | 1999 | 2902 | 0.080 |
Why?
|
| Diabetes Mellitus | 2 | 2006 | 5835 | 0.080 |
Why?
|
| Infant, Premature, Diseases | 1 | 2015 | 710 | 0.080 |
Why?
|
| Glycemic Index | 3 | 2006 | 395 | 0.080 |
Why?
|
| Multivariate Analysis | 10 | 2014 | 12054 | 0.080 |
Why?
|
| Birth Weight | 2 | 2015 | 2098 | 0.080 |
Why?
|
| Respiration | 1 | 1995 | 1657 | 0.080 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2011 | 461 | 0.080 |
Why?
|
| Alcohol Drinking | 2 | 2001 | 4026 | 0.080 |
Why?
|
| Fetal Growth Retardation | 1 | 2011 | 579 | 0.070 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2017 | 2750 | 0.070 |
Why?
|
| Norway | 1 | 2008 | 497 | 0.070 |
Why?
|
| Body Weight | 3 | 2009 | 4614 | 0.070 |
Why?
|
| Hypoglycemia | 1 | 1994 | 884 | 0.070 |
Why?
|
| Follicular Phase | 1 | 2006 | 143 | 0.070 |
Why?
|
| Luteal Phase | 1 | 2006 | 138 | 0.070 |
Why?
|
| Risk | 6 | 2013 | 9605 | 0.060 |
Why?
|
| Proinsulin | 1 | 2005 | 135 | 0.060 |
Why?
|
| Gestational Age | 2 | 2011 | 3574 | 0.060 |
Why?
|
| Incidence | 12 | 2014 | 21322 | 0.060 |
Why?
|
| Insurance, Health | 1 | 2017 | 2491 | 0.060 |
Why?
|
| Thinness | 1 | 2008 | 490 | 0.060 |
Why?
|
| Cohort Studies | 11 | 2022 | 41366 | 0.060 |
Why?
|
| Fetus | 1 | 2011 | 1863 | 0.060 |
Why?
|
| Dominican Republic | 2 | 2014 | 76 | 0.060 |
Why?
|
| Career Mobility | 1 | 2006 | 258 | 0.060 |
Why?
|
| Magnesium | 2 | 2006 | 809 | 0.060 |
Why?
|
| Albuminuria | 1 | 2007 | 650 | 0.060 |
Why?
|
| Pandemics | 2 | 2021 | 8623 | 0.060 |
Why?
|
| Massachusetts | 6 | 2014 | 8826 | 0.050 |
Why?
|
| Meat | 1 | 2006 | 585 | 0.050 |
Why?
|
| Death | 1 | 2007 | 676 | 0.050 |
Why?
|
| Life Style | 5 | 2014 | 3909 | 0.050 |
Why?
|
| Endarterectomy, Carotid | 1 | 2008 | 555 | 0.050 |
Why?
|
| Maternal Age | 2 | 2013 | 809 | 0.050 |
Why?
|
| Dietary Fiber | 1 | 2006 | 759 | 0.050 |
Why?
|
| Health Education | 1 | 2009 | 1052 | 0.050 |
Why?
|
| Blood Pressure | 5 | 2006 | 8479 | 0.050 |
Why?
|
| Carotid Arteries | 1 | 2006 | 941 | 0.050 |
Why?
|
| Overweight | 2 | 2015 | 2412 | 0.050 |
Why?
|
| Stress, Psychological | 2 | 2014 | 4475 | 0.050 |
Why?
|
| Diet | 3 | 2006 | 8058 | 0.050 |
Why?
|
| Regression Analysis | 3 | 2001 | 6340 | 0.050 |
Why?
|
| Sex Distribution | 1 | 2006 | 2281 | 0.050 |
Why?
|
| Carotid Stenosis | 1 | 2008 | 860 | 0.050 |
Why?
|
| Middle Aged | 23 | 2022 | 220382 | 0.040 |
Why?
|
| Hot Flashes | 1 | 2003 | 330 | 0.040 |
Why?
|
| Sunlight | 1 | 2001 | 337 | 0.040 |
Why?
|
| Premature Birth | 1 | 2011 | 1780 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2015 | 7996 | 0.040 |
Why?
|
| Eclampsia | 1 | 1999 | 56 | 0.040 |
Why?
|
| Body Height | 2 | 2002 | 1570 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2013 | 10180 | 0.040 |
Why?
|
| Immunization, Passive | 1 | 2020 | 616 | 0.040 |
Why?
|
| Osteoclasts | 1 | 2002 | 711 | 0.040 |
Why?
|
| Adolescent | 9 | 2022 | 88196 | 0.040 |
Why?
|
| Young Adult | 8 | 2022 | 59068 | 0.040 |
Why?
|
| Child | 3 | 2022 | 80086 | 0.040 |
Why?
|
| Combined Modality Therapy | 2 | 2003 | 8522 | 0.040 |
Why?
|
| Pregnancy Complications, Hematologic | 1 | 1999 | 179 | 0.040 |
Why?
|
| Hot Temperature | 1 | 2024 | 1440 | 0.040 |
Why?
|
| Walking | 3 | 2001 | 1199 | 0.040 |
Why?
|
| Infant, Newborn | 3 | 2013 | 26280 | 0.040 |
Why?
|
| Women's Health Services | 1 | 2017 | 88 | 0.030 |
Why?
|
| Kidney Diseases | 1 | 2007 | 2093 | 0.030 |
Why?
|
| Smoking | 4 | 2002 | 9046 | 0.030 |
Why?
|
| Nadolol | 1 | 1996 | 29 | 0.030 |
Why?
|
| Renin | 2 | 1996 | 639 | 0.030 |
Why?
|
| Cesarean Section | 1 | 2005 | 1393 | 0.030 |
Why?
|
| Foam Cells | 1 | 1996 | 68 | 0.030 |
Why?
|
| Stents | 1 | 2008 | 3177 | 0.030 |
Why?
|
| Multicenter Studies as Topic | 2 | 2013 | 1703 | 0.030 |
Why?
|
| Nifedipine | 1 | 1996 | 221 | 0.030 |
Why?
|
| Myocardial Infarction | 3 | 2002 | 11453 | 0.030 |
Why?
|
| Case-Control Studies | 5 | 2005 | 22097 | 0.030 |
Why?
|
| Trust | 1 | 2020 | 530 | 0.030 |
Why?
|
| State Health Plans | 1 | 2017 | 219 | 0.030 |
Why?
|
| Diabetes Complications | 1 | 2002 | 1317 | 0.030 |
Why?
|
| Saphenous Vein | 2 | 1996 | 518 | 0.030 |
Why?
|
| Lactates | 1 | 1995 | 404 | 0.030 |
Why?
|
| Popliteal Vein | 1 | 1994 | 43 | 0.030 |
Why?
|
| Longevity | 1 | 2022 | 1062 | 0.030 |
Why?
|
| Endothelin-1 | 1 | 1996 | 302 | 0.030 |
Why?
|
| Potassium | 2 | 1996 | 1311 | 0.030 |
Why?
|
| Syndrome | 1 | 2001 | 3267 | 0.030 |
Why?
|
| Aminoglutethimide | 1 | 1994 | 13 | 0.030 |
Why?
|
| Plicamycin | 1 | 1994 | 12 | 0.030 |
Why?
|
| Chelation Therapy | 1 | 1994 | 77 | 0.030 |
Why?
|
| Mitotane | 1 | 1994 | 20 | 0.030 |
Why?
|
| Varicose Ulcer | 1 | 1994 | 55 | 0.030 |
Why?
|
| Propylthiouracil | 1 | 1994 | 68 | 0.030 |
Why?
|
| Femoral Vein | 1 | 1994 | 153 | 0.030 |
Why?
|
| Diazoxide | 1 | 1994 | 52 | 0.030 |
Why?
|
| Mineralocorticoids | 1 | 1994 | 37 | 0.030 |
Why?
|
| Adrenalectomy | 1 | 1996 | 346 | 0.030 |
Why?
|
| Edetic Acid | 1 | 1994 | 283 | 0.030 |
Why?
|
| Bromocriptine | 1 | 1994 | 93 | 0.030 |
Why?
|
| Aldosterone | 2 | 1996 | 866 | 0.030 |
Why?
|
| Ketoconazole | 1 | 1994 | 97 | 0.030 |
Why?
|
| Inappropriate ADH Syndrome | 1 | 1994 | 61 | 0.030 |
Why?
|
| Depression | 1 | 2013 | 8104 | 0.030 |
Why?
|
| Hemangiopericytoma | 1 | 1994 | 71 | 0.030 |
Why?
|
| Therapeutic Equipoise | 1 | 2013 | 28 | 0.030 |
Why?
|
| Logistic Models | 3 | 2013 | 13240 | 0.030 |
Why?
|
| Drug Approval | 1 | 2020 | 811 | 0.030 |
Why?
|
| Saline Solution, Hypertonic | 1 | 1994 | 114 | 0.030 |
Why?
|
| Weight Loss | 1 | 2004 | 2683 | 0.030 |
Why?
|
| Octreotide | 1 | 1994 | 153 | 0.030 |
Why?
|
| Mifepristone | 1 | 1994 | 150 | 0.030 |
Why?
|
| Phosphorus | 1 | 1994 | 336 | 0.030 |
Why?
|
| Calcitonin | 1 | 1994 | 329 | 0.030 |
Why?
|
| Hypoglycemic Agents | 1 | 2005 | 3076 | 0.030 |
Why?
|
| Registries | 1 | 2008 | 8216 | 0.030 |
Why?
|
| Intermittent Claudication | 1 | 1994 | 304 | 0.020 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 1994 | 616 | 0.020 |
Why?
|
| Arteriosclerosis | 1 | 1996 | 1055 | 0.020 |
Why?
|
| Somatostatin | 1 | 1994 | 447 | 0.020 |
Why?
|
| Hyperthyroidism | 1 | 1994 | 292 | 0.020 |
Why?
|
| Vasodilator Agents | 1 | 1996 | 973 | 0.020 |
Why?
|
| Myocardial Ischemia | 1 | 2002 | 2110 | 0.020 |
Why?
|
| Placebos | 1 | 1995 | 1661 | 0.020 |
Why?
|
| Carbon Dioxide | 1 | 1995 | 1146 | 0.020 |
Why?
|
| Arteries | 1 | 1996 | 1125 | 0.020 |
Why?
|
| Age Factors | 3 | 2008 | 18379 | 0.020 |
Why?
|
| Follow-Up Studies | 8 | 2007 | 39078 | 0.020 |
Why?
|
| Smoking Cessation | 1 | 2003 | 2053 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1995 | 2498 | 0.020 |
Why?
|
| Stroke | 3 | 2002 | 9745 | 0.020 |
Why?
|
| Male | 13 | 2013 | 360035 | 0.020 |
Why?
|
| Boston | 2 | 2000 | 9326 | 0.020 |
Why?
|
| Exercise Tolerance | 1 | 1995 | 835 | 0.020 |
Why?
|
| Socioeconomic Factors | 2 | 2014 | 7817 | 0.020 |
Why?
|
| Fluid Therapy | 1 | 1994 | 580 | 0.020 |
Why?
|
| Sodium, Dietary | 1 | 1993 | 425 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 1995 | 1859 | 0.020 |
Why?
|
| Pregnancy Trimester, First | 1 | 2013 | 907 | 0.020 |
Why?
|
| Hormones | 1 | 1993 | 867 | 0.020 |
Why?
|
| Aged | 10 | 2008 | 168840 | 0.020 |
Why?
|
| Prevalence | 2 | 2014 | 15698 | 0.020 |
Why?
|
| Waist-Hip Ratio | 1 | 2009 | 518 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 1997 | 2633 | 0.020 |
Why?
|
| Estrogens | 1 | 1994 | 1519 | 0.020 |
Why?
|
| Guidelines as Topic | 1 | 2013 | 1385 | 0.020 |
Why?
|
| Menarche | 1 | 2009 | 532 | 0.020 |
Why?
|
| Odds Ratio | 2 | 2013 | 9639 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2013 | 2683 | 0.020 |
Why?
|
| Medical History Taking | 1 | 2009 | 773 | 0.020 |
Why?
|
| Heart Function Tests | 1 | 2006 | 318 | 0.020 |
Why?
|
| Breast Neoplasms | 2 | 2003 | 20985 | 0.020 |
Why?
|
| Inflammation | 1 | 2005 | 10746 | 0.020 |
Why?
|
| Forecasting | 1 | 1994 | 2925 | 0.020 |
Why?
|
| Cooking | 1 | 2006 | 312 | 0.010 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2005 | 277 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 1996 | 4430 | 0.010 |
Why?
|
| Primary Health Care | 1 | 2000 | 4674 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1996 | 10759 | 0.010 |
Why?
|
| Age Distribution | 2 | 2002 | 2878 | 0.010 |
Why?
|
| Hypolipidemic Agents | 1 | 2008 | 609 | 0.010 |
Why?
|
| C-Peptide | 1 | 2005 | 440 | 0.010 |
Why?
|
| Poverty | 1 | 2015 | 2694 | 0.010 |
Why?
|
| Patient Education as Topic | 1 | 2013 | 2318 | 0.010 |
Why?
|
| Melanoma | 1 | 2001 | 5704 | 0.010 |
Why?
|
| Blood Pressure Determination | 1 | 2006 | 634 | 0.010 |
Why?
|
| Triage | 1 | 1989 | 986 | 0.010 |
Why?
|
| Vascular Resistance | 1 | 2005 | 932 | 0.010 |
Why?
|
| Creatinine | 1 | 2007 | 1898 | 0.010 |
Why?
|
| Activities of Daily Living | 2 | 2006 | 2420 | 0.010 |
Why?
|
| Skin Neoplasms | 1 | 2001 | 5815 | 0.010 |
Why?
|
| Renin-Angiotensin System | 1 | 2006 | 737 | 0.010 |
Why?
|
| Temperance | 1 | 2001 | 87 | 0.010 |
Why?
|
| Breast Feeding | 1 | 2009 | 1357 | 0.010 |
Why?
|
| Macrophages | 1 | 1996 | 5764 | 0.010 |
Why?
|
| Fruit | 1 | 2006 | 1160 | 0.010 |
Why?
|
| Vegetables | 1 | 2006 | 1195 | 0.010 |
Why?
|
| Washington | 1 | 2001 | 315 | 0.010 |
Why?
|
| Survival Rate | 2 | 2007 | 12698 | 0.010 |
Why?
|
| Sunburn | 1 | 2001 | 156 | 0.010 |
Why?
|
| Nutrition Assessment | 1 | 2003 | 728 | 0.010 |
Why?
|
| Thyroid Neoplasms | 1 | 1994 | 2331 | 0.010 |
Why?
|
| Infant, Premature | 1 | 2009 | 2104 | 0.010 |
Why?
|
| Mass Screening | 1 | 1996 | 5424 | 0.010 |
Why?
|
| Indoles | 1 | 2007 | 1833 | 0.010 |
Why?
|
| Neoplasms | 2 | 1999 | 22083 | 0.010 |
Why?
|
| Hospitals, Maternity | 1 | 1999 | 33 | 0.010 |
Why?
|
| Adiponectin | 1 | 2005 | 1113 | 0.010 |
Why?
|
| Glomerular Filtration Rate | 1 | 2007 | 2171 | 0.010 |
Why?
|
| Magnesium Sulfate | 1 | 1999 | 73 | 0.010 |
Why?
|
| Infusions, Intravenous | 2 | 1994 | 2217 | 0.010 |
Why?
|
| Energy Intake | 1 | 2006 | 2134 | 0.010 |
Why?
|
| Phenytoin | 1 | 1999 | 189 | 0.010 |
Why?
|
| Residence Characteristics | 1 | 2008 | 2087 | 0.010 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2005 | 1649 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 1996 | 20078 | 0.010 |
Why?
|
| Fasting | 1 | 2003 | 1600 | 0.010 |
Why?
|
| Time Factors | 3 | 2008 | 39947 | 0.010 |
Why?
|
| Body Constitution | 1 | 1997 | 273 | 0.010 |
Why?
|
| Probability | 1 | 2002 | 2476 | 0.010 |
Why?
|
| Reference Values | 1 | 2003 | 4921 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2002 | 2927 | 0.010 |
Why?
|
| Giant Cells | 1 | 1996 | 188 | 0.010 |
Why?
|
| Age of Onset | 1 | 2002 | 3302 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2005 | 3209 | 0.010 |
Why?
|
| Receptors, Estrogen | 1 | 2003 | 2204 | 0.010 |
Why?
|
| Plethysmography | 1 | 1994 | 175 | 0.010 |
Why?
|
| Folic Acid | 1 | 2001 | 1315 | 0.010 |
Why?
|
| Ultrasonography, Doppler, Duplex | 1 | 1994 | 198 | 0.010 |
Why?
|
| Pain | 1 | 1989 | 5075 | 0.010 |
Why?
|
| Linear Models | 1 | 2003 | 5865 | 0.010 |
Why?
|
| C-Reactive Protein | 1 | 2005 | 3822 | 0.010 |
Why?
|
| Blood Volume | 1 | 1994 | 548 | 0.010 |
Why?
|
| Cross-Sectional Studies | 2 | 2005 | 26063 | 0.010 |
Why?
|
| Varicose Veins | 1 | 1994 | 155 | 0.010 |
Why?
|
| Glucose Clamp Technique | 1 | 1993 | 263 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2007 | 9309 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1996 | 20551 | 0.010 |
Why?
|
| Cell Count | 1 | 1996 | 1834 | 0.010 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 1993 | 393 | 0.010 |
Why?
|
| Vascular Patency | 1 | 1994 | 904 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2007 | 15257 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 1994 | 1487 | 0.010 |
Why?
|
| Growth Hormone | 1 | 1993 | 568 | 0.010 |
Why?
|
| Cause of Death | 1 | 2001 | 3686 | 0.010 |
Why?
|
| Risk Assessment | 2 | 2002 | 23953 | 0.010 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1996 | 1492 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 1999 | 80430 | 0.010 |
Why?
|
| Leg | 1 | 1994 | 1089 | 0.010 |
Why?
|
| Anticonvulsants | 1 | 1999 | 1903 | 0.010 |
Why?
|
| Energy Metabolism | 1 | 1999 | 2875 | 0.000 |
Why?
|
| Dietary Supplements | 1 | 2001 | 3405 | 0.000 |
Why?
|
| Sodium | 1 | 1993 | 1589 | 0.000 |
Why?
|
| Comorbidity | 1 | 2002 | 10494 | 0.000 |
Why?
|
| Child, Preschool | 1 | 2009 | 42209 | 0.000 |
Why?
|
| Affect | 1 | 1994 | 1483 | 0.000 |
Why?
|
| Environmental Exposure | 1 | 2001 | 4443 | 0.000 |
Why?
|
| Longitudinal Studies | 1 | 2002 | 14565 | 0.000 |
Why?
|
| Dopamine | 1 | 1993 | 1603 | 0.000 |
Why?
|
| Hydrocortisone | 1 | 1993 | 1815 | 0.000 |
Why?
|
| Gene Expression | 1 | 1996 | 7582 | 0.000 |
Why?
|
| Homeostasis | 1 | 1993 | 3320 | 0.000 |
Why?
|
| Double-Blind Method | 1 | 1994 | 12320 | 0.000 |
Why?
|